NO20056241L - Nanopartikler av polyoksyetylenerte derivater - Google Patents

Nanopartikler av polyoksyetylenerte derivater

Info

Publication number
NO20056241L
NO20056241L NO20056241A NO20056241A NO20056241L NO 20056241 L NO20056241 L NO 20056241L NO 20056241 A NO20056241 A NO 20056241A NO 20056241 A NO20056241 A NO 20056241A NO 20056241 L NO20056241 L NO 20056241L
Authority
NO
Norway
Prior art keywords
nanoparticles
polyoxyethylenated derivatives
pharmaceutically
cosmetically active
polyoxyethylene
Prior art date
Application number
NO20056241A
Other languages
English (en)
Norwegian (no)
Inventor
Jose Alonso Fernandez
Alejandro Sanchez Barreiro
Noemi Csaba
Original Assignee
Advanced In Vitro Cell Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Advanced In Vitro Cell Tech filed Critical Advanced In Vitro Cell Tech
Publication of NO20056241L publication Critical patent/NO20056241L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B23—MACHINE TOOLS; METAL-WORKING NOT OTHERWISE PROVIDED FOR
    • B23K—SOLDERING OR UNSOLDERING; WELDING; CLADDING OR PLATING BY SOLDERING OR WELDING; CUTTING BY APPLYING HEAT LOCALLY, e.g. FLAME CUTTING; WORKING BY LASER BEAM
    • B23K11/00—Resistance welding; Severing by resistance heating
    • B23K11/24—Electric supply or control circuits therefor
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physics & Mathematics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20056241A 2003-07-04 2005-12-29 Nanopartikler av polyoksyetylenerte derivater NO20056241L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200301570A ES2232287B1 (es) 2003-07-04 2003-07-04 Nanoparticulas de derivados polioxietilenados.
PCT/ES2004/000282 WO2005002550A1 (fr) 2003-07-04 2004-06-17 Nanoparticules de derives polyoxyethylenes

Publications (1)

Publication Number Publication Date
NO20056241L true NO20056241L (no) 2005-12-29

Family

ID=33560937

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20056241A NO20056241L (no) 2003-07-04 2005-12-29 Nanopartikler av polyoksyetylenerte derivater

Country Status (10)

Country Link
US (1) US20060153923A1 (fr)
EP (1) EP1658842A1 (fr)
JP (1) JP2007525474A (fr)
KR (1) KR20060026956A (fr)
AU (1) AU2004253308A1 (fr)
BR (1) BRPI0411954A (fr)
CA (1) CA2531111A1 (fr)
ES (1) ES2232287B1 (fr)
NO (1) NO20056241L (fr)
WO (1) WO2005002550A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2044934A1 (fr) * 2007-10-01 2009-04-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Dispersion de particules de protéines poloxamères, les méthodes de production et l'emploi de cette dispersion
US20090105368A1 (en) * 2007-10-19 2009-04-23 Bisco, Inc. Time-controlled intraoral film former system for intraoral use
ES2358403B2 (es) * 2009-10-26 2011-12-13 Universidad De Santiago De Compostela Sistema para la administración de sustancias biológicamente activas que comprende poli-epsilón-caprolactona, poloxamina y una o varias sustancias activas.
WO2012059936A1 (fr) 2010-11-03 2012-05-10 Padma Venkitachalam Devarajan Compositions pharmaceutiques destinées à l'administration de médicaments colloïdaux
CN102008731B (zh) * 2010-12-14 2012-06-27 上海纳米技术及应用国家工程研究中心有限公司 以嵌段共聚物为载体的氟碳化合物纳米载药制剂的制备方法
ES2385995B2 (es) * 2011-01-10 2013-05-21 Universidade De Santiago De Compostela Nanocápsulas con cubierta polimérica
CN103635182A (zh) * 2011-05-09 2014-03-12 萨里亚化学研究院 用于药物递送的聚合物纳米颗粒
KR101367365B1 (ko) * 2012-01-18 2014-02-27 고려대학교 산학협력단 생체적합성 입자 및 이의 제조방법
CN104382866B (zh) * 2014-11-12 2017-08-01 中国人民解放军第二军医大学 一种包载两种表面活性剂的抗肿瘤耐药的纳米递释系统及其制备方法
WO2021158627A1 (fr) * 2020-02-03 2021-08-12 Memorial Sloan Kettering Cancer Center Compositions comprenant des nanoparticules et procédés associés
WO2023168387A1 (fr) * 2022-03-04 2023-09-07 West Pharmaceutical Services, Inc. Systèmes, compositions et procédés de conservation à basse température de cellules, de bioencres, d'hydrogels et de produits médicinaux modifiés par génie tissulaire (temps)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4582865A (en) * 1984-12-06 1986-04-15 Biomatrix, Inc. Cross-linked gels of hyaluronic acid and products containing such gels
GB8601100D0 (en) * 1986-01-17 1986-02-19 Cosmas Damian Ltd Drug delivery system
FR2608988B1 (fr) * 1986-12-31 1991-01-11 Centre Nat Rech Scient Procede de preparation de systemes colloidaux dispersibles d'une substance, sous forme de nanoparticules
IT1247472B (it) * 1991-05-31 1994-12-17 Fidia Spa Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
US5565215A (en) * 1993-07-23 1996-10-15 Massachusettes Institute Of Technology Biodegradable injectable particles for imaging
US5543158A (en) * 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US20010053359A1 (en) * 1994-07-26 2001-12-20 Peter Watts Drug delivery composition for the nasal administration of antiviral agents
CA2207961A1 (fr) * 1995-01-05 1996-07-11 Robert J. Levy Nanoparticules a modification de surface et leurs procedes de fabrication et d'utilisation
CA2214889C (fr) * 1995-03-10 2005-05-24 Hans Koll Formes galeniques pharmaceutiques contenant un polypeptide, sous forme de microparticules, et leur procede de preparation
EP0752245B1 (fr) * 1995-07-05 2002-05-22 European Community Nanoparticules biocompatibles et biodégradables conçues pour l'absorption et l'administration de médicaments protéiniques
US7276251B2 (en) * 1997-04-01 2007-10-02 Lg Life Sciences, Ltd., Inc. Sustained-release composition of drugs encapsulated in microparticles of hyaluronic acid
FR2777193B1 (fr) * 1998-04-14 2001-06-08 Coletica Particule a groupement hydroxamique chelatante d'ions metalliques et leur utilisation en cosmetique ou en pharmacie
FR2777895A1 (fr) * 1998-04-28 1999-10-29 Debio Rech Pharma Sa Polymere sequence non-reticule,procede pour sa preparation, et ses utilisations
US20030059465A1 (en) * 1998-05-11 2003-03-27 Unger Evan C. Stabilized nanoparticle formulations of camptotheca derivatives
IN191203B (fr) * 1999-02-17 2003-10-04 Amarnath Prof Maitra
AU4476600A (en) * 1999-04-22 2000-11-10 Vanderbilt University Polymeric encapsulation system promoting angiogenesis
US6743446B2 (en) * 1999-12-15 2004-06-01 The Ohio State University Research Foundation Methods for stabilizing biologically active agents encapsulated in biodegradable controlled-release polymers
US6465425B1 (en) * 2000-02-10 2002-10-15 Alkermes Controlled Therapeutics, Inc. Microencapsulation and sustained release of biologically active acid-stable or free sulfhydryl-containing proteins
EP1187602A4 (fr) * 2000-04-18 2004-09-15 Peptron Inc Composition pharmaceutique injectable a liberation durable et procedes de preparation de celle-ci
AU2003304108B2 (en) * 2002-10-30 2007-03-22 Spherics, Inc. Nanoparticulate bioactive agents

Also Published As

Publication number Publication date
WO2005002550A1 (fr) 2005-01-13
US20060153923A1 (en) 2006-07-13
ES2232287B1 (es) 2006-11-01
KR20060026956A (ko) 2006-03-24
BRPI0411954A (pt) 2006-08-15
CA2531111A1 (fr) 2005-01-13
EP1658842A1 (fr) 2006-05-24
AU2004253308A1 (en) 2005-01-13
ES2232287A1 (es) 2005-05-16
JP2007525474A (ja) 2007-09-06

Similar Documents

Publication Publication Date Title
NO20056241L (no) Nanopartikler av polyoksyetylenerte derivater
ATE544447T1 (de) Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
ATE334663T1 (de) Arzneimittelzusammensetzung mit verzögerter wirkstoffabgabe
SI1898876T1 (sl) MUKOADHEZIVNE FARMACEVTSKE OBLIKE, KI VSEBUJEJO KSILOGlUKAN IN SO UPORABNE V MEDICINSKIH SREDSTVIH IN APLIKACIJSKIH OBLIKAH
ATE515949T1 (de) Süssware
BR0212475A (pt) Composições farmacêuticas
BG105857A (en) Pregelatinized starch in a controlled release formulation
NO20025621D0 (no) Farmasöytisk sammensetning med vedvarende frigjöring for parenteral administrasjon av hydrofile forbindelser
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
MY130332A (en) Pharmaceutical formulation comprising iota-carrageenan and at least one neutral gelling polymer
WO2004098564A3 (fr) Nanoparticules biodegradables integrant des medicaments hautement hydrophiles et positivement charges
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
PT1425005E (pt) Composicao farmaceutica que compreende lumiracoxib
BRPI0414305A (pt) sistema de liberação de drogas por via oral
WO2005107702A3 (fr) Compositions pharmaceutiques vaginales mucoadhesives a liberation prolongee
DE60202590D1 (de) 2h-1-benzopyran-derivate, prozesse zu ihrer herstellung und pharmazeutische zusammensetzungen
UA89656C2 (ru) Фармацевтическая композиция, которая диспергируется перорально, и способ ее приготовления
WO2002034240A3 (fr) Formulations a liberation retardee et prolongee et procede d'utilisation
SE0001916D0 (sv) Novel formulation
DK1653923T3 (da) Oral afleveringssystem omfattende en bivæsket skum
ATE256134T1 (de) Sulfatierte phosphatidylinositole, ihre herstellung und verwendung
WO2002053099A3 (fr) Methodes et compositions de traitement d'une parodontopathie
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
HRP20040165B1 (en) Citalopram for the treatment of elevated blood pressure
WO2002041875A3 (fr) Procede de fabrication de formulations pharmaceutiques facilement solubles et formulations correspondantes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application